THE EFFECT OF A GROUP OF AYURVEDIC MEDICINES ON SVITRA (VITILIGO) AMONG CHILDRE

Phase 2

• Conditions: Health Condition 1: L80- Vitiligo

• Registration Number: CTRI/2021/02/031275
• Lead Sponsor: All India Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Children of age group 3-16 years of either gender.

2. Patients with Sadhya Lakshana of Svitra (Peeta chavi, Pandu varna, Ruksha).

3. Patients having Svitra patches with normal tactile sensation.

4. Patients with Twak svetata mandatorily, and preferably any or all of Roukshya, Kandu, Daha, Vivarnata (Roma) in the subjective symptom scoring.

5. Patients who are willing to participate in study.

Exclusion Criteria

1. Patients not willing to participate in the study, and beyond the age range 3-16 years.

2. Lesion over the palms, genital & burnt areas.

3. Patients currently on other systems of medication or Ayurvedic medication.

4. Vitiligo associated with malignant melanoma, albinism and psoriasis.

5. Patient suffering from other systemic diseases (like bronchial asthma, URTI, etc.) & autoimmune disorders (Eg: Celiac disease, Type I Diabetes mellitus, Inflammable Bowel Disease, etc.) which are Apatarpanajanya.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in subjective symptoms, Vitiligo Extensive Tensity Index score and increase in pigmentation.Timepoint: 46TH AND 91ST DAYS

Secondary Outcome Measures

Name	Time	Method
Improvement in Dermatological Life Quality Index.Timepoint: 46TH AND 91ST DAYS